Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for Recurrent Miscarriage in IVF/ICSI
NCT01788540Phase 4Completed
- Sponsor
- Woman's Health University Hospital
- Start
- Feb 2013
- Primary completion
- Aug 2016
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Intralipid 10% in recurrent miscarriage (RPL), sponsored by Woman's Health University Hospital. Started Feb 2013; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT01788540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01788540.